Alberto M Pereira Arias

Learn More
OBJECTIVE Most patients with differentiated thyroid carcinoma (DTC) undergo total thyroidectomy followed by routine radioiodide thyroid remnant ablation. Most centres that routinely perform radioiodide ablation prescribe a low-iodide diet (LID) to increase the radioiodide accumulation in thyroid remnants. The efficacy of an LID on thyroid remnant ablation,(More)
Objective: Whole body hyperthermia (WBH) in combination with chemotherapy is a relatively new promising treatment modality for patients with cancer. The objective of this report is to present the development of an acute systemic inflammatory response syndrome (SIRS) with multiple organ dysfunction syndrome (MODS) following WBH in combination with(More)
INTRODUCTION Depot preparations of long-acting somatostatin analogues are being used increasingly in the treatment of GH hypersecretion in patients with acromegaly, either as primary treatment or as secondary treatment following incomplete surgery. In 60% of these patients, Sandostatin long-acting release (LAR), the depot preparation of octreotide, achieves(More)
In healthy subjects, paracrine factors partly regulate insulin secretion and basal endogenous glucose production. Administration of pentoxifylline, an adenosine receptor antagonist, inhibits transiently endogenous glucose production in healthy humans without any changes in glucoregulatory hormone concentrations. To evaluate the modulatory role of adenosine(More)
OBJECTIVE To evaluate the long-term outcome of transsphenoidal resection of pituitary adenomas at the Leiden University Medical Center (LUMC), The Netherlands. DESIGN Retrospective, descriptive. METHOD 416 consecutive patients undergoing surgery for pituitary adenoma at the LUMC between 1978 and 2004 were included; 174 patients with non-functioning(More)
OP 1 Oral Agents in the Management of Diabetes A 3 OP 2 Epidemiology of Type 2 Diabetes ........ A 5 OP 3 Experimental Immunology I ............ A 7 OP 4 Nephropathy I ..................... A 9 OP 5 Retinopathy ....................... A 11 OP 6 Mechanisms of Beta-Cell Destruction and Regeneration . . . . . . . . . . . . . . . . . . . A 13 OP 7 Experimental(More)
  • 1